Subjective
|
|
Today, patient... ******
|
Sleep *****
|
Appetite *****
|
Energy *****
|
Compliance to Medication is *****
|
Side Effects to psychotropics reported *****
|
|
|
Objective
|
|
Video Visit
|
|
General Appearance:
|
Attitude & Behavior:
|
Psychomotor
|
Speech:
|
Mood:
|
Affect:
|
Thought Content:
|
Thought Process:
|
Perception:
|
Hallucination Content:
|
Sensorium:
|
Cognition:
|
Impulse Control:
|
Insight:
|
|
Judgement:
|
LAB & DIAGNOSTICS
|
|
LAST SESSION PSYCHOTROPIC MEDICATIONS:
|
|
Phone Visit Only
|
|
General Appearance:
|
Attitude & Behavior:
|
Psychomotor
|
Speech:
|
Mood:
|
Affect:
|
Thought Content:
|
Thought Process:
|
Perception:
|
Hallucination Content:
|
Sensorium:
|
Cognition:
|
Impulse Control:
|
Insight:
|
|
Judgement:
|
LAB & DIAGNOSTICS
|
|
LAST SESSION PSYCHOTROPIC MEDICATIONS:
|
|
|
|
Assessment & Plan
|
|
BIOLOGICAL TREATMENT:
|
1.
|
|
2.
|
|
Benefits/Risks/Alternatives were addressed
|
|
Informed consent was obtained and filed
|
|
Patient advised to bring back metabolic syndrome info
|
|
|
PSYCHOSOCIAL TREATMENT:
|
Provided Supportive/ Educational therapy
|
|
Provided Intervention
|
|
Client Response
|
|
|
1: 1 Psychotherapy
|
|
Medical Necessity of Office Visit
|
|
|
|
Session Time in minutes
|
|
Documentation Time in minutes
|
|
Return to Clinic in weeks
|
|